Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search

Restenosis

Citations 41-50 of 74 total displayed.

Past content (since Mar 1999):

Articles
Novel NAD(P)H Oxidase Inhibitor Suppresses Angioplasty-Induced Superoxide and Neointimal Hyperplasia of Rat Carotid Artery
Gary M. Jacobson, Hector M. Dourron, Jianhua Liu, Oscar A. Carretero, Daniel J. Reddy, Tanja Andrzejewski, and Patrick J. Pagano
Circ. Res. published February 27, 2003, doi:10.1161/01.RES.0000063423.94645.8A [Abstract]  

Molecular Medicine
Neuron-Derived Orphan Receptor-1 (NOR-1) Modulates Vascular Smooth Muscle Cell Proliferation
José Martínez-González, Jordi Rius, Ana Castelló, Claudia Cases-Langhoff, and Lina Badimon
Circ. Res. 2003;92:96-103; published online before print as doi:10.1161/01.RES.0000050921.53008.47 [Abstract] [Full text]  

Articles
Neuron-Derived Orphan Receptor-1 (NOR-1) Modulates Vascular Smooth Muscle Cell Proliferation
José Martínez-González, Jordi Rius, Ana Castelló, Claudia Cases-Langhoff, and Lina Badimon
Circ. Res. published December 19, 2002, doi:10.1161/01.RES.0000050921.53008.47 [Abstract]  

Integrative Physiology
Physical Training Increases eNOS Vascular Expression and Activity and Reduces Restenosis After Balloon Angioplasty or Arterial Stenting in Rats
Ciro Indolfi, Daniele Torella, Carmela Coppola, Antonio Curcio, Francisca Rodriguez, Antonio Bilancio, Antonio Leccia, Oreste Arcucci, Mariacristina Falco, Dario Leosco, and Massimo Chiariello
Circ. Res. 2002;91:1190-1197; published online before print as doi:10.1161/01.RES.0000046233.94299.D6 [Abstract] [Full text]  

Editorials
Targeting Pericellular Proteolysis in Vascular Disease
Michelle P. Bendeck
Circ. Res. 2002;91:861-862, doi:10.1161/01.RES.0000043396.97121.9C [Full text]  

Integrative Physiology
Gene Transfer of the Urokinase-Type Plasminogen Activator Receptor-Targeted Matrix Metalloproteinase Inhibitor TIMP-1.ATF Suppresses Neointima Formation More Efficiently Than Tissue Inhibitor of Metalloproteinase-1
M.L.M. Lamfers, J.M. Grimbergen, M.C. Aalders, M.J. Havenga, M.R. de Vries, L.G.M. Huisman, V.W.M. van Hinsbergh, and P.H.A. Quax
Circ. Res. 2002;91:945-952; published online before print as doi:10.1161/01.RES.0000041418.51906.57 [Abstract] [Full text]  

Articles
Physical Training Increases eNOS Vascular Expression and Activity and Reduces Restenosis After Balloon Angioplasty or Arterial Stenting in Rats
Ciro Indolfi, Daniele Torella, Carmela Coppola, Antonio Curcio, Francisca Rodriguez, Antonio Bilancio, Antonio Leccia, Oreste Arcucci, Mariacristina Falco, Dario Leosco, and Massimo Chiariello
Circ. Res. published November 7, 2002, doi:10.1161/01.RES.0000046233.94299.D6 [Abstract]  

Articles
Gene Transfer of the Urokinase-Type Plasminogen Activator Receptor-Targeted Matrix Metalloproteinase Inhibitor TIMP-1.ATF Suppresses Neointima Formation More Efficiently Than Tissue Inhibitor of Metalloproteinase-1
M. L.M. Lamfers, J. M. Grimbergen, M. C. Aalders, M. J. Havenga, M. R. de Vries, L. G.M. Huisman, V. W.M. van Hinsbergh, and P. H.A. Quax
Circ. Res. published October 10, 2002, doi:10.1161/01.RES.0000041418.51906.57 [Abstract]  

Molecular Medicine
Accelerated Atherosclerosis and Calcification in Vein Grafts: A Study in APOE*3 Leiden Transgenic Mice
J.H.P. Lardenoye, M.R. de Vries, C.W.G.M. Löwik, Q. Xu, C.R. Dhore, J.P.M. Cleutjens, V.W.M. van Hinsbergh, J.H. van Bockel, and P.H.A. Quax
Circ. Res. 2002;91:577-584; published online before print as doi:10.1161/01.RES.0000036901.58329.D7 [Abstract] [Full text]  

Editorials
Transcription Factor Decoy
Victor J. Dzau
Circ. Res. 2002;90:1234-1236, doi:10.1161/01.RES.0000025209.24283.73 [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8

* Subspecialty Collections Home

* Show  Restenosis
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment